RHOADS v. BOEHRINGER INGELHEIM PHARMACEUTICALS INC | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for RHOADS v. BOEHRINGER INGELHEIM PHARMACEUTICALS INC

Sort by

Viewing results 1‒25 of 42

US politics & policy
US targets 10 drugs for pricing negotiations in crackdown on costs
...The initial list of 10 drugs to face price negotiations includes a diabetes pill called Jardiance sold by Boehringer Ingelheim and Eli Lilly; a medicine to prevent strokes called Eliquis made by Pfizer and...
August 29, 2023
Pharmaceuticals sector
GSK and Sanofi shares surge after Zantac ruling victory
...The ruling was a significant win for the pharmaceutical companies GSK, Pfizer, Sanofi and Boehringer Ingelheim....
December 6, 2022
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
Coronavirus
US hospitals panic-buy drugs ahead of coronavirus influx
...Drugmakers GSK and Boehringer Ingelheim are now rationing inhalers, according to Premier....
March 21, 2020
AbbVie Inc
AbbVie raises guidance as cancer treatments boost sales
...Ingelheim, after it received approval....
July 26, 2019
News in-depthPharmaceuticals sector
Rivals line up to take on world’s best-selling drug
...Another company, Boehringer Ingelheim of Germany, remains in patent litigation with AbbVie and has no plans for a European launch, despite its medicine being approved for sale in the EU....
October 14, 2018
LexPharmaceuticals sector
Pfizer: swallowing hard Premium content
...That would have been close to the multiple of 22 times operating earnings before usual deductions used to price Sanofi’s €21.8bn asset swap with Boehringer Ingelheim last year....
March 23, 2018
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
Pharmaceuticals sector
Valeant to return ‘female Viagra’ maker to former owners
...Addyi was first developed as an antidepressant in the 1990s by Boehringer Ingelheim, the German pharmaceuticals group, but failed to make it through clinical trials....
November 6, 2017
News in-depthUS & Canadian companies
Pharma turns to big data to gauge care and pricing
...Boehringer Ingelheim, Europe’s biggest private drugmaker, hired Simone Menne as chief financial officer from airline Lufthansa....
July 11, 2017
Small Talk - BooksKate Burgess
Dechra confident of winning best in show among the rare breeds
...Even so, the big multinationals — under pressure to focus — have been hiving off their animal medicine arms: Novartis to Eli Lilly; Sanofi of France to Boehringer Ingelheim....
September 11, 2016
World
Hikma profits eroded by weaker generics business
...Ingelheim in July....
March 16, 2016
IPOs
Samsung biopharma unit lines up South Korea IPO
...Samsung Biologics ranks third behind Lonza of Switzerland and Boehringer Ingelheim of Germany....
August 12, 2016
Mergers & Acquisitions
Hikma share drop accelerates
...Jordan-founded but UK-listed Hikma initially agreed to buy the business from Boehringer Ingelheim in July, declaring that the deal would transform its scale and position in the US....
February 10, 2016
World
Sanofi and Boehringer Ingelheim discuss asset swap
...Another day, another potential pharmaceuticals deal....
December 15, 2015
Mergers & Acquisitions
Hikma shares sink after it chops offer price for Roxane
...Jordan-founded but UK-listed Hikma initially agreed to buy the business from Boehringer Ingelheim in July, declaring that the deal would transform its scale and position in the US....
February 10, 2016
US & Canadian companies
Medivation agrees to $10bn takeover talks
...Sanofi last month completed a €22.8bn asset swap with Boehringer Ingelheim, which allowed the French group to trade its animal health unit and gain a new consumer-health focused business as well as a €4.7bn...
July 5, 2016
FT Live
Global Private Banking Awards 2024
Celebrating excellence in wealth management
Thursday, 7 NovemberThe Landmark London, London, UK
US & Canadian companies
Sanofi threatens to go hostile in $9.3bn pursuit of Medivation
...The first was an €18bn asset swap with Boehringer Ingelheim agreed last December, which, once completed, will see Sanofi trade its animal health unit for the German group’s consumer health business....
May 5, 2016
US & Canadian companies
Sanofi makes $9.3bn unsolicited cash offer for Medivation
...In December 2015, Sanofi entered talks with Boehringer Ingelheim over an €18bn asset exchange that would see the French drugmaker swap its animal health unit for the German company’s consumer health business...
April 28, 2016
LexPharmaceuticals sector
Sanofi/Boehringer: swap shop
...In pharmaceuticals at least, it is making a comeback....
December 15, 2015
US & Canadian companies
Slaughter and May elects new senior partner
...As head of the firm’s M&A practice, Mr Cooke recently led the team advising Hikma Pharmaceuticals on its $2.65bn acquisition of Roxane from Boehringer Ingelheim, and Shire on its proposed merger with AbbVie...
January 7, 2016
LexPharmaceuticals sector
Animal health: double or quits
...Possible buyers include Zoetis and pharma groups that still have animal health divisions: Lilly, Bayer and possibly Boehringer Ingelheim, which is privately held....
November 13, 2015
US & Canadian companies
What $32bn deal for Baxalta means to Shire
...Based on 2014 revenues, the combined entity would have ranked 21st among global pharma groups with $12bn of sales, behind Boehringer Ingelheim but above big names such as Biogen....
January 11, 2016
US & Canadian companies
Valeant buys maker of ‘female Viagra’ for $1bn
...Addyi was first developed as an antidepressant in the 1990s by Boehringer Ingelheim, the German pharmaceuticals group, but failed to make it through clinical trials....
August 20, 2015
US & Canadian companies
S1 Biopharma starts trial of female libido drug
...After the rejection Boehringer Ingelheim sold rights in the drug to Sprout Pharmaceuticals, a new company in North Carolina, which has conducted further clinical trials – showing more significant benefits...
July 28, 2013
European companies
Court stops EU regulator releasing drug trial data
...Boehringer Ingelheim of Germany filed for information on InterMune’s products. Both rivals were developing similar compounds....
April 30, 2013
European companies
Boehringer criticises German drug test
...Christian Boehringer, chairman of Boehringer Ingelheim, warned of a threat to Europe’s healthcare systems as governments sought to save costs....
May 7, 2012

Previous pagePage 1 of 2Next page